Esperion Therapeutics Stock Analysis

Esperion Stock Analysis Notes

About 66.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.67. Esperion Therapeutics had not issued any dividends in recent years. The entity had 1:6 split on the 11th of June 2013. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 218 people. To learn more about Esperion Therapeutics call Sheldon Koenig at 734 887 3903 or check out https://www.esperion.com.

Esperion Therapeutics Investment Alerts

Esperion Therapeutics Upcoming and Recent Events

Esperion Largest EPS Surprises

View All Earnings Estimates

Esperion Therapeutics Environmental, Social, and Governance (ESG) Scores

Esperion Therapeutics Thematic Classifications

Esperion Stock Institutional Investors

Note, although Esperion Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Esperion Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 506.38 M.

Esperion Profitablity

The company has Profit Margin (PM) of (0.29) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.

Management Efficiency

Esperion Therapeutics has return on total asset (ROA) of 0.0384 % which means that it generated a profit of $0.0384 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6079) %, meaning that it created substantial loss on money invested by shareholders. Esperion Therapeutics' management efficiency ratios could be used to measure how well Esperion Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/26/2024, Return On Equity is likely to grow to 0.48, while Return On Tangible Assets are likely to drop (1.07). As of 11/26/2024, Debt To Assets is likely to grow to 2.74, while Total Assets are likely to drop slightly above 181.9 M.

Technical Drivers

As of the 26th of November, Esperion Therapeutics shows the Downside Deviation of 3.99, mean deviation of 3.4, and Coefficient Of Variation of 683.68. Esperion Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Esperion Therapeutics standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Esperion Therapeutics is priced favorably, providing market reflects its regular price of 2.57 per share. Please also check Esperion Therapeutics total risk alpha, which is currently at (0.05) to verify the company can sustain itself at a future point.

Esperion Therapeutics Price Movement Analysis

Esperion Therapeutics Insider Trading Activities

Esperion Therapeutics Outstanding Bonds

Esperion Therapeutics Predictive Daily Indicators

Esperion Therapeutics Corporate Filings

Esperion Therapeutics Forecast Models

Esperion Therapeutics' time-series forecasting models are one of many Esperion Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Esperion Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Esperion Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Esperion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Esperion Therapeutics. By using and applying Esperion Stock analysis, traders can create a robust methodology for identifying Esperion entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Esperion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Esperion analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Esperion Therapeutics stock analysis indicators help investors evaluate how Esperion Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Esperion Therapeutics shares will generate the highest return on investment. By understating and applying Esperion Therapeutics stock analysis, traders can identify Esperion Therapeutics position entry and exit signals to maximize returns.

When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.